<unk> (nasal) is an H1 receptor antagonist that is FDA approved for the {{{indicationType}}} of seasonal allergic rhinitis in adults and children 6 years of age and older.   Common adverse reactions include bitter taste, headache, epistaxis, pharyngolaryngeal pain, post-nasal drip, cough, urinary tract infection, upper respiratory tract infection, pyrexia, and rash.
Olopatadine 
Dolastetron 
Loratadine
Rupatadine
Avacopan
Lerisetron
Palonosetron
Tropisetron